Regulating Hybrids: ‘Making a Mess’ and ‘Cleaning Up’ in Tissue Engineering and Transpecies Transplantation

This paper explores the institutional regulation of novel biosciences, hybrid technologies that often disturb and challenge existing regulatory frameworks. Developing a conceptual vocabulary for understanding the relationship between material and institutional hybrids, the paper compares human tissue engineering (TE) and xenotransplantation (XT), areas of innovation which regulators have sought to govern separately and in isolation from one another. Contrasting definitional boundaries and regulatory mechanisms partition them socio-institutionally. But despite these attempts at purification, TE and XT have proven increasingly difficult to tell apart in practical and material terms. Human and animal matters, cell cultures and tissue products have much greater corporeal connection than has been institutionally recognized, and are therefore a source of acute instability in the regulation of implants and transplants. This paper tells the story of how the messy worlds of TE and XT have leaked into one another, calling into question the abilities of regulation to adequately control hybrid innovations.

[1]  Henry G. Small,et al.  Mapping the dynamics of science and technology , 1988, Scientometrics.

[2]  Paul A. Martin Genetic governance: The risks, oversight and regulation of genetic databases in the UK , 2001 .

[3]  C. Waldby Stem Cells, Tissue Cultures and the Production of Biovalue , 2002 .

[4]  L. Sharp Bodies, boundaries, and territorial disputes: Investigating the Murky Realm of scientific authority , 2002, Medical anthropology.

[5]  T. P. Hughes,et al.  Networks of Power: Electrification in Western Society , 1984 .

[6]  R. Lamb,et al.  Of Bicycles, Bakelites, and Bulbs: Toward a Theory of Sociotechnical Change , 1996, Inf. Process. Manag..

[7]  R. Fox,et al.  Leaving the field. , 1992, The Hastings center report.

[8]  C. Blacker,et al.  The courage to fail. A social view of organ transplants and dialysis , 1976, Medical History.

[9]  Karen Barad,et al.  Five. Getting Real: Technoscientific Practices and the Materialization of Reality , 1998 .

[10]  B. Latour Why Has Critique Run out of Steam? From Matters of Fact to Matters of Concern , 2004, Critical Inquiry.

[11]  K. Knorr-Cetina,et al.  Epistemic cultures : how the sciences make knowledge , 1999 .

[12]  Cyrus C. M. Mody A Little Dirt Never Hurt Anyone: , 2001 .

[13]  B. Latour We Have Never Been Modern , 1991 .

[14]  S. Franklin Culturing Biology: Cell Lines for the Second Millennium , 2001 .

[15]  M. Douglas,et al.  Purity and Danger: An Analysis of Concepts of Pollution and Taboo. , 1967 .

[16]  M. Gibbons,et al.  Re-Thinking Science: Knowledge and the Public in an Age of Uncertainty , 2003 .

[17]  B. Latour Science in Action , 1987 .

[18]  A. Barry Political Machines: Governing a Technological Society , 2001 .

[19]  H. Rheinberger Beyond nature and culture. Modes of reasoning in the age of molecular biology , 2000 .

[20]  David Bloor,et al.  Polyhedra and the Abominations of Leviticus , 1978, British Journal for the History of Science.

[21]  G. Weiss,et al.  Body Images: Embodiment as Intercorporeality , 1998 .

[22]  F. Guattari,et al.  A Thousand Plateaus: Capitalism and Schizophrenia , 1980 .

[23]  Paul Rabinow,et al.  Artificiality and Enlightenment: From Sociobiology to Biosociality , 2008, The Ethics of Biotechnology.

[24]  M. Lock,et al.  Remaking life and death: Toward an Anthropology of the Biosciences , 2003 .

[25]  Mike Michael,et al.  Risky creatures: Institutional species boundary change in biotechnology regulation , 2004 .

[26]  Paul Martin,et al.  The Drugs Don't Work , 2003, Social studies of science.

[27]  B. Prins,et al.  The Ethics of Hybrid Subjects: Feminist Constructivism According to Donna Haraway , 1995 .

[28]  Robert Bud Resistance to new technology: In the engine of industry: regulators of biotechnology, 1970–86 , 1995 .

[29]  Andrew Webster,et al.  New Medical Technologies and Society: Reordering Life , 2004 .

[30]  L. Hogle Claims and disclaimers: Whose expertise counts? , 2002, Medical anthropology.

[31]  Julie Kent,et al.  Human tissue engineered products—drugs or devices? , 2003, BMJ : British Medical Journal.

[32]  A. Faulkner,et al.  Towards governance of human tissue engineered technologies in Europe: Framing the case for a new regulatory regime , 2006 .

[33]  C. Hood,et al.  The Government of Risk: Understanding Risk Regulation Regimes , 2001 .

[34]  Martin Bauer Resistance to New Technology: Nuclear Power, Information Technology, Biotechnology , 1995 .

[35]  H. Rheinberger Living and Working with the New Medical Technologies: Beyond nature and culture: modes of reasoning in the age of molecular biology and medicine , 2000 .

[36]  G. Pugliese,et al.  PHS Guideline on Infectious Disease Issues in Xenotransplantation , 2001, Infection Control & Hospital Epidemiology.

[37]  Hilary Rose,et al.  Modest_Witness@Second_Millenium. Femaleman. copyright Meets_OncoMouse trademark: Feminism and Technoscience. Donna J. Haraway , 1998 .